Condition | Neurology

SENTIS

  • IRB Number: 905
  • Contact Name: Cheryl Weber, RN, MS, CCRC
  • Status: Enrolling
  • Phone: 585-922-4111
  • Lead Researcher: W. Scott Burgin, MD

Description

Safety and Efficacy of NeuroFlo Technology In Ischemic Stroke (SENTIS): A Study of Care Intensity and Outcomes of Neuroflo® (SCION) To compare treatment for ischemic stroke outcome with NeuroFlo plus standard medical management vs. standard medical management alone. Enrollment : 244 patients at 80 US sites, aged 18 years and older, diagnosed with a focal neurological deficit due to ischemia, with a baseline NIHSS between 5 and 18, in whom the NeuroFlo procedure will begin within 14 hours of symptom onset in those patients randomized to treatment.